China’s Mindray Gets U.S. FDA Clearance For New Imaging System
This article was originally published in PharmAsia News
Executive Summary
The U.S. FDA has cleared a new type of ultrasound imaging system developed by China's Mindray Medical International. Mindray already had approval from China's State FDA and European regulators for its DC-3 color system used in abdominal, cardiac, endovaginal and OB/GYN treatments. The device is intended to complement its DC-6 and MS systems, but the difference is DC-3 is intended for the low-end markets. (Click here for more